Stocks in the News: Palm, CIGNA, Teva, Borders

The following is a round-up of the most active gainers and losers from Friday's trading session:

Best Buy (BBY) increased 1.3%, or 54 cents per share, after analysts boosted their ratings for the retailer from neutral to buy on indications it could benefit from an economic recovery.

Google (GOOG) sunk 1%, or $6.37 per share, as reports surfaced this week that the Internet search engine will exit the China market by the end of next month.

Palm (PALM) shares sunk to a 52-week low after the smart-phone maker warned that its fourth-quarter revenues would be cut in half. The stock dropped 28.5%, or $1.61 per share.

Perry Ellis International's (PERY) better-than-expected earnings didn't affect its stock, which fell 9%, or $2.07 per share.

Ford's (F) stock price ended its climb Friday. The automakers' stock fell 3%, or 44 cents per share. Earlier this week, Ford hit a five-year high.

Pfizer (PFE) fell nearly 2%, or 32 cents per share, after its attempt to buy a generic drug company, Ratiopharm Group International, failed. It was outbid by drug-maker Teva Pharmaceuticals (TEVA), which finished up 1.6%, or $1.02 or per share, touching a 52-week high during trading.

PolyOne (POL), which makes plastic construction products, rose 15%, or $1.39 per share, after forecasting earnings above estimates based on increasing demand and new business.

Bank of America (BAC) shares fell 1.5%, or 26 cents a share, after analysts cut estimates.

Borders Group (BGP), a book retailer, fell 17%, or 39 cents a share. The stock rose earlier this week on news of rival Barnes & Noble's (BKS) new CEO.

Health care stocks got a boost from this weekend's pending vote on a national health care overhaul bill. UnitedHealth Group (UNH) rose 2.35%, or 79 cents a share. CIGNA (CI) rose 3.5%, or $1.24 per share.
Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.